Amrutanjan Health Care Ltd. (AMRUTANJAN) Share Price Falls 8.73% Today

Amrutanjan Health Care Ltd. Share Price fell to Rs 488 on 12 August 2026, down 8.73% from the previous close of Rs 534.7, bringing the company’s market capitalisation to Rs 1,532.55 crore. That move places the stock among the notable top decliner names in today’s Stock Market Today session, and it also cleared the event bar for its Small Cap category under Univest’s price-fall tracking framework.

What happened today is clear from the verified market data: the stock opened at Rs 544, rose as high as Rs 550.5 during the session, and then declined sharply to an intraday low of Rs 486 before trading near Rs 488 at the event timestamp. The supplied data confirms the price event, but it does not establish a company-specific catalyst behind the move. Even so, the size of the share price decline makes Amrutanjan Health Care Ltd. Stock News relevant for traders following market movers, Pharmaceuticals counters, and Healthcare names facing selling pressure.

Why is the stock trending? The answer lies in the magnitude of the day’s decline, the swing from the day’s high to low, and the stock’s place within a Healthcare company set where valuation and profitability metrics can be compared directly. Important financial metrics include a P/E ratio of 26.69, P/B ratio of 4.18, ROE of 32.69, ROCE of 44, EPS of 20.03 and dividend yield of 0.92. Investors tracking Amrutanjan Health Care Ltd. Share Price Today may now watch whether price action stabilises after this fall and how its valuation stacks up against sector and peer benchmarks. Throughout this analysis, Univest focuses only on supplied, verifiable data.

Amrutanjan Health Care Ltd. (AMRUTANJAN) Share Price Today: Price Action Analysis

Amrutanjan Health Care Ltd. (AMRUTANJAN) traded at Rs 488. versus the previous close of Rs 534.7, a fall of 8.73%. The stock opened at Rs 544, reached Rs 550.5, touched Rs 486. Reported volume was 32,128.

Amrutanjan Health Care Ltd. (AMRUTANJAN) Fundamental Analysis

Amrutanjan Health Care Ltd. was valued at a P/E ratio of 26.69x, a P/B ratio of 4.18x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 32.69% and ROCE of 44%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 20.03, dividend yield of 0.92%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Amrutanjan Health Care Ltd. Fundamental Analysis starts with scale and valuation. The company’s market cap stands at Rs 1,532.55 crore, placing it firmly in the Small Cap bracket. Its P/E ratio is 26.69 and its P/B ratio is 4.18. These are valuation multiples, so they need context rather than a standalone judgement. Within the supplied Healthcare and Pharmaceuticals & Drugs benchmark, the company’s P/E sits above the industry median of 24.45 but well below the average of 79.31, while the P/B ratio is above both the median of 1.82 and average of 2.46.

Profitability is one of the stronger parts of the supplied financial picture. Return on equity is 32.69 and return on capital employed is 44. Those figures are materially above the benchmark medians and averages provided for the same industry set, which suggests that the business has been generating stronger returns on shareholder capital and operating capital than a large part of its direct comparison universe.

EPS is 20.03, which means the earnings attributable to each share are Rs 20.03 on the supplied basis. That is useful when read together with the current stock price and P/E ratio because it helps explain how the market is valuing those earnings after today’s decline. Dividend yield is 0.92, indicating a historical payout relative to the current market price, though it should be treated as a current data point rather than an assurance of future distribution.

The broader takeaway from this Amrutanjan Health Care Ltd. Stock Analysis is mixed but informative. On one hand, the valuation is not extremely stretched against the industry average P/E, and profitability ratios are notably strong. On the other hand, the P/B ratio is richer than many peers and the industry median, which means investors may already be paying a premium for quality or capital efficiency. That blend of solid returns and above-median valuation is exactly why today’s weakness in Amrutanjan Health Care Ltd. Share Price is drawing attention on Univest and why it makes sense to examine ownership structure only when reported and sector context in more detail.

Sector and Industry Context

Amrutanjan Health Care Ltd. (AMRUTANJAN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Amrutanjan Health Care Ltd. (AMRUTANJAN) has a P/E ratio of 26.69x, which is above the benchmark median of 24.45x, a difference of +9.16%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Amrutanjan Health Care Ltd. (AMRUTANJAN) has a ROE of 32.69%, which is above the benchmark median of 10.49%, a difference of +211.63%. Amrutanjan Health Care Ltd. (AMRUTANJAN) has a ROCE of 44%, which is above the benchmark median of 12.97%, a difference of +239.24%.

Track today’s top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Amrutanjan Health Care Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry, and the supplied benchmark covers 136 companies in the same industry. That breadth makes the comparison useful because it places today’s stock move inside a broader valuation and profitability context rather than treating the fall in isolation.

The company P/E of 26.69 is above the benchmark median of 24.45 but far below the benchmark average of 79.31. The range itself is wide, from 3.31 to 3,374.81 across 104 companies with P/E data, so the industry clearly includes both lower-valued and very highly valued names. In that context, Amrutanjan Health Care Ltd. Share Price is not trading at the extreme end of the sector on earnings multiple. However, the P/B ratio of 4.18 is above the benchmark median of 1.82 and average of 2.46 across 135 companies, showing that the stock carries a richer book-value multiple than the broader comparison set.

Where the company stands out more clearly is profitability. Its ROE of 32.69 is well above the benchmark median of 10.49 and average of 8.1. Its ROCE of 44 is also comfortably above the benchmark median of 12.97 and average of 15.64. That indicates stronger capital efficiency than many stocks in the same Pharmaceuticals & Drugs universe. In market-cap terms, the company at Rs 1,532.55 crore is also above the industry median market capitalisation of Rs 146.94 crore and above the average of Rs 484.32 crore, though still below the largest benchmark constituent at Rs 2,949.87 crore.

For investors following Amrutanjan Health Care Ltd. Latest News and broader Market News, the sector comparison suggests a business that screens strong on returns but not especially cheap on book value. That matters because a stock with above-benchmark profitability can still see near-term pressure if the market reprices valuations or if sentiment weakens across Healthcare names. Univest therefore treats this market decline as notable not simply because of the one-day move, but because the stock sits in a part of the industry where both quality and valuation are already in focus.

Peer Comparison

Amrutanjan Health Care Ltd. (AMRUTANJAN) has a P/E ratio of 26.69x compared with the displayed peer median of 31.07x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 32.69% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 44% versus the displayed peer median of 15.34%, providing a capital-efficiency comparison. Amrutanjan Health Care Ltd. (AMRUTANJAN) has a market capitalisation of Rs 1,532.55 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Peer comparison helps answer whether Amrutanjan Health Care Ltd. Share Price is falling from a relatively expensive or relatively efficient position within its direct listed universe. Against the supplied peer set, the company’s market cap of Rs 1,532.55 crore is smaller than Dishman Carbogen Amcis at Rs 2,949.87 crore, Beta Drugs at Rs 2,775.9 crore, Hikal at Rs 2,761.32 crore, Sai Parenteral’s at Rs 2,594.65 crore and several other peers listed in the comparison basket. That means it is not the largest name in this peer group.

On valuation, its P/E of 26.69 is lower than Dishman Carbogen Amcis at 31.07, Beta Drugs at 71.31, Sai Parenteral’s at 179.52, NGL Fine-Chem at 44.41, Ind-Swift Laboratories at 43.16 and Indoco Remedies at 355.2. It is therefore trading on a lower earnings multiple than several peers with available P/E data. At the same time, its P/B ratio of 4.18 is higher than Hikal at 2.26, Sai Parenteral’s at 3.32, Solara at 1.92, Panacea Biotec at 2.95, Ind-Swift Laboratories at 1.65 and Indoco Remedies at 1.99, though lower than Beta Drugs at 11.28 and NGL Fine-Chem at 6.49.

Profitability is where the company looks stronger. ROE at 32.69 exceeds Beta Drugs at 18.65, Hikal at 15.22, Sai Parenteral’s at 13.9, Solara at 17.23, Panacea Biotec at 0, NGL Fine-Chem at 27.9, Hester Biosciences at 16.17 and Indoco Remedies at 12.85. ROCE at 44 is also above the figures shown for all the named peers in the supplied set, including NGL Fine-Chem at 33.91 and Beta Drugs at 22.17.

This peer picture makes the current Amrutanjan Health Care Ltd. Share Price News especially interesting. The stock does not look like the cheapest on book value, but it does look stronger than most of the peer set on return ratios while still carrying a lower P/E than several comparison names. That combination explains why today’s weakness is worth tracking closely on Univest as part of a broader Amrutanjan Health Care Ltd. Fundamental Analysis rather than as a single-session fluctuation.

Why Investors Are Watching Amrutanjan Health Care Ltd.

Investors are watching this counter because today’s fall was large enough to place it in the top decliner conversation while the company still shows relatively strong profitability metrics versus its Pharmaceuticals & Drugs comparison set. In other words, the share price decline is happening in a stock that does not look operationally weak on the supplied return ratios, which naturally raises interest in near-term price behaviour and valuation re-rating.

• Verified price action: the stock fell 8.73% to Rs 488 from Rs 534.7, after opening at Rs 544 and touching Rs 550.5 before sliding to Rs 486.
• Volume participation: total volume reached 5,19,255 shares across BSE and NSE, with heavier activity on NSE.
• Fundamental context: P/E is 26.69, P/B is 4.18, ROE is 32.69, ROCE is 44, EPS is 20.03 and dividend yield is 0.92.
• Sector positioning: profitability sits above industry medians and averages, while valuation is above the industry median on both P/E and P/B.
• Peer standing: return ratios compare favourably with several listed peers, even though market cap is smaller than many names in the same basket.

What should investors monitor next? The main watch points are whether Amrutanjan Health Care Ltd. Share Price Today holds near the day’s low or stabilises after the decline, whether valuation compresses further relative to the peer set, and whether the stock continues to trade with elevated activity in the next set of market sessions. Univest users typically combine these signals with broader sector moves rather than relying on a single day’s Market Update.

About Amrutanjan Health Care Ltd.

Amrutanjan Health Care Ltd. is classified within the Healthcare sector and the Pharmaceuticals & Drugs industry. Based on the supplied dataset, the most reliable company context available is its market positioning inside that industry set and the financial profile attached to the stock. With a market capitalisation of Rs 1,532.55 crore, the company is larger than the median company size in its benchmark universe, though smaller than several of the direct peers listed in the comparison snapshot.

The market also values the business using profitability-led metrics. A P/E of 26.69 and P/B of 4.18 suggest that investors are not pricing it like a distressed or deeply discounted Healthcare name. Instead, the stock appears to sit in the category of companies where capital efficiency matters. That is reinforced by the supplied ROE of 32.69 and ROCE of 44, both of which stand out against industry medians and averages.

For readers searching Amrutanjan Health Care Ltd. Company News, AMRUTANJAN NSE updates or AMRUTANJAN BSE data, the most important immediate context is that this is a listed Pharmaceuticals & Drugs company whose stock performance is now being judged against both sector multiples and peer return ratios. Today’s price fall therefore matters not just as an isolated trading event, but as a re-pricing move in a company with above-benchmark profitability figures. Univest will continue to frame such Stock Updates around verified market data and direct comparables.

Track Amrutanjan Health Care Ltd. Share Price on Univest

Use Amrutanjan Health Care Ltd. (AMRUTANJAN) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

On Univest, users can track Amrutanjan Health Care Ltd. Share Price through live price updates, day change data, market capitalisation, valuation ratios and broader stock analysis tools. That includes monitoring Amrutanjan Health Care Ltd. Share Price Today alongside key metrics such as P/E, P/B, ROE, ROCE, EPS and dividend yield, all of which help place daily moves in context.

Univest also helps investors follow 52-week levels, shareholding pattern updates when available, exchange-wise volume trends, sector comparisons and peer benchmarking. For anyone researching Amrutanjan Health Care Ltd. Stock News, the value lies in seeing today’s Market Decline together with fundamentals, relative valuation and industry positioning rather than viewing price action alone. That approach can be especially useful when a stock enters the Stocks in News list because of a sharp single-session move.

Frequently Asked Questions

Why did Amrutanjan Health Care Ltd. Share Price fall today?

Ans. Amrutanjan Health Care Ltd. Share Price fell 8.73% to Rs 488 from the previous close of Rs 534.7. The supplied data confirms the sharp price fall and intraday weakness, but it does not establish a company-specific catalyst for the move.

What was the intraday range for Amrutanjan Health Care Ltd. today?

Ans. The stock opened at Rs 544, touched a day high of Rs 550.5 and fell to a day low of Rs 486. Trading near Rs 488 at the event time showed the stock remained close to the lower end of.

What is the market capitalisation of Amrutanjan Health Care Ltd.?

Ans. Amrutanjan Health Care Ltd. had a market capitalisation of Rs 1,532.55 crore at the time of this update. That places it in the Small Cap category, which is why today’s sizeable decline qualified for this tracked event.

How much volume was traded in Amrutanjan Health Care Ltd. shares?

Ans. Total traded volume stood at 5,19,255 shares, with 32,128 shares on BSE and 4,87,127 shares on NSE. The tracked exchange turnover was Rs 1.57 crore, showing that the day’s fall came with visible market participation.

Is Amrutanjan Health Care Ltd. expensive compared with its industry?

Ans. The company’s P/E ratio is 26.69, above the same-industry median of 24.45 but below the average of 79.31. Its P/B ratio of 4.18 is above both the industry median of 1.82 and average of 2.46.

How strong are Amrutanjan Health Care Ltd.'s profitability ratios?

Ans. The company’s ROE is 32.69 and ROCE is 44, both stronger than the supplied industry median and average figures. That suggests Amrutanjan Health Care Ltd. generates higher returns on capital than many companies in its benchmark set.

What does EPS and dividend yield show for Amrutanjan Health Care Ltd.?

Ans. EPS stands at 20.03, indicating the earnings attributable to each share on the supplied basis. Dividend yield is 0.92, which reflects the historical payout relative to the current share price rather than any assured future distribution.

How does Amrutanjan Health Care Ltd. compare with peers on valuation?

Ans. Its P/E of 26.69 is lower than several supplied peers including Beta Drugs, Sai Parenteral’s and Indoco Remedies. However, its P/B of 4.18 is higher than many peers, showing a mixed but quality-linked valuation profile.

How does Amrutanjan Health Care Ltd. compare with peers on returns?

Ans. Amrutanjan Health Care Ltd. shows ROE of 32.69 and ROCE of 44, both ahead of the return ratios listed for the supplied peer set. That makes profitability one of the company’s strongest comparative financial markers despite today’s stock decline.

What should investors monitor after this Amrutanjan Health Care Ltd. share price fall?

Ans. Investors may monitor whether the stock stabilises after falling to Rs 488, whether trading activity stays elevated after today’s 5,19,255-share volume, and how its valuation and profitability continue to compare with Pharmaceuticals & Drugs sector benchmarks.